Catalyst
Slingshot members are tracking this event:
Kite Pharma (KITE) Research with National Cancer Institute Evaluating T-Cell Therapy in KRAS Mutant Metastatic Colorectal Cancer Published in New England Journal of Medicine
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
National Institutes Of Health, T-cell Therapy, Kras Mutant Metastatic Coloractal Cancer, New England Journal Of Medicine, National Cancer Institute
